about
Molecular targets for antiepileptic drug developmentCentral serotonin-2A (5-HT2A) receptor dysfunction in depression and epilepsy: the missing link?Lamotrigine effects sensorimotor gating in WAG/Rij rats.Long-term valproate treatment increases brain neuropeptide Y expression and decreases seizure expression in a genetic rat model of absence epilepsyPharmacological treatment of childhood absence epilepsy.Ethosuximide and phenytoin dose-dependently attenuate acute nonconvulsive seizures after traumatic brain injury in rats.Allosteric modulators of GABA(B) receptors: mechanism of action and therapeutic perspective.The CaV2.3 R-type voltage-gated Ca2+ channel in mouse sleep architectureGABAergic drugs in the treatment of epilepsy: modern or outmoded?Emerging drugs for focal epilepsy.Current and emerging treatments for absence seizures in young patientsInvestigation of spinal nerve ligation-mediated functional activation of the rat brain using manganese-enhanced MRI.Beta and gamma range EEG power-spectrum correlation with spiking discharges in DBA/2J mice absence model: role of GABA receptors.Regulation of Thalamic and Cortical Network Synchrony by Scn8a.The pathways connecting the hippocampal formation, the thalamic reuniens nucleus and the thalamic reticular nucleus in the rat.Levetiracetam in the treatment of idiopathic generalized epilepsies.On-off intermittency in time series of spontaneous paroxysmal activity in rats with genetic absence epilepsy.Investigation of the pruritus-induced functional activity in the rat brain using manganese-enhanced MRI.A GABRB3 promoter haplotype associated with childhood absence epilepsy impairs transcriptional activity.Do the quantitative relationships of synaptic junctions and terminals in the thalamus of genetic absence epilepsy rats from Strasbourg (GAERS) differ from those in normal control Wistar rats.On the origin and suddenness of absences in genetic absence models.Effect of GABAB receptor antagonist (CGP35348) on learning and memory in albino mice.The investigation of EEG specificity in epileptic children during Depakine therapy.Altered thalamic GABAA-receptor subunit expression in the stargazer mouse model of absence epilepsy.
P2860
Q24683346-922E20AA-BDF1-420D-8D54-6D3F6B833260Q28080944-0B177C56-CC12-48F6-AB24-36023A8031B6Q30464975-EE0FBCC5-93C7-4FCC-9BA7-BEF0653CDB9CQ31139176-FAAA2A71-F07D-4879-9540-B772BE6C2942Q36511313-0C668DA8-FFD7-43DF-8D57-121188E2656DQ37334696-3A5CB396-2054-406B-A63A-4F14A069CCB9Q37420482-5D6619B0-5203-48A9-A66C-D0C025BF6937Q37700412-701BA159-D7F1-410B-968B-DEF099021DD0Q37856281-F9B12C77-01CB-4C9E-84CA-9593CD170398Q38062011-A97EF6C4-96E9-4C59-9898-571D5297FA78Q38124030-D8BD80D7-06C4-4A8B-A7DC-01C33A63E88CQ39152240-A8440E9F-B9F6-4314-AF5D-FF3AFA5E671FQ39748232-15BF0A16-476F-491A-8E03-76801C3C6F72Q46070864-C162590E-CEDC-48FE-BE3C-3C348D74B74DQ46790258-9AA6823D-50B5-468A-899B-CF7B58B7A57CQ46816008-43212516-2F45-4DB0-B4C0-CAFF45D9D55DQ48321085-B90F9127-0FEE-40E1-8AE4-DB294F3815D6Q48397898-659D89E4-9DAA-4CD4-8DB0-307118D2E072Q48474436-B6107472-B94E-4F99-8640-ADD64088D994Q49104475-5F90DB08-A1D7-4E6B-9FB7-EBB7FF56BEEFQ49162675-7716D638-78F5-4128-AB94-515B92CCDF5EQ51157765-C557D800-FD26-478B-B028-A70D6CC6A022Q52150986-F6BDFA7A-073E-456E-8198-61CEF11F9FBBQ52646826-FC21AAF4-411F-4E3F-89D9-1C1B7EFC8AEA
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Pharmacology of absence epilepsy.
@ast
Pharmacology of absence epilepsy.
@en
type
label
Pharmacology of absence epilepsy.
@ast
Pharmacology of absence epilepsy.
@en
prefLabel
Pharmacology of absence epilepsy.
@ast
Pharmacology of absence epilepsy.
@en
P2093
P1476
Pharmacology of absence epilepsy.
@en
P2093
Douglas A Richards
Jon-Paul A Manning
Norman G Bowery
P304
P356
10.1016/J.TIPS.2003.08.006
P577
2003-10-01T00:00:00Z